Corporate News

11 September 2023

Celtarys and G.CLIPS join forces to revolutionize transmembrane proteins characterization in drug discovery. 

A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions […]
7 July 2023

Discover Our New Fluorescent Ligands For AT1

Our portfolio of #GPCR#fluorescent ligands is growing.We have just added to our catalogue more fluorescent ligands for the AT1 receptor, CELT-145 and CELT-252. The Angiotensin AT1 receptor belongs to the […]
27 March 2023

New article showcasing Celtarys  fluorescent ligand for Dopamine D3 Receptor in Fluorescence based HTS

Celtarys Research collaborates with several research groups in Europe for the validation of our products in different assays commonly used in drug discovery, always with the […]
3 March 2023

Discover Our New Fluorescent Ligands For C5a Receptor

Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue more fluorescent ligands for the C5a receptor, CELT-58 and CELT-68. The C5a anaphylatoxin chemotactic receptor 1 (C5aR, also […]
19 December 2022

Celtarys Research has signed a strategic research cooperation agreement with the European platform EU-OPENSCREEN

We are glad to announce that Celtarys Research has reached a strategic research cooperation agreement with the European platform EU-OPENSCREEN (https://www.eu-openscreen.eu ), a not-for-profit European Research Infrastructure […]
9 November 2022

Celtarys Research, sponsor of the XIV Meeting of the Spanish Drug Discovery Network

The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
20 September 2022

Fluorescent ligands: A New Method to Label your GPCRs

To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022

Celtarys Adenosine Receptor fluorescent ligands as potent tools for the study of cancer specific GPCRs

The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022

Celtarys Research and Chemspace sign a distribution agreement for the commercialization of Celtarys products

We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]